| Similar Articles |
|---|
 |
Health
October 19, 2009
Cara Birnbaum |
What Doctors Don't Tell You About C-sections Here's the real story, and what every woman needs to know before she gets pregnant.   |
BusinessWeek
September 27, 2004
Carol Marie Cropper |
Women's Surgery: Less of an Ordeal Laparoscopy -- a minimally invasive technique -- can cut recovery times, leave smaller scars, reduce in-hopital stays, and lower costs. But many gynecologists are not trained to perform these operations, so you may have to ask for it. |
Chemistry World
February 16, 2015
Phillip Broadwith |
US approves internal tissue glue TissuGlu from Cohera Medical is already approved in Europe, but is the first internal adhesive to be approved in the US. |
Chemistry World
July 17, 2009
Hayley Birch |
No scars with healing nanosheet Biodegradable nanomaterials could prevent scarring after surgery according to Japanese researchers. They say their polyester-based nanosheets seamlessly seal up surgical incisions in mice |
Health
July 2007
Curt Pesmen |
The Scary Truth About Surgery The 5 operations you don't want to get and what to do instead. |
Nursing
March 2009
Kate J. Morse |
Focusing on the Surgical Patient with Cardiac Problems Learn about the latest guidelines for assessing cardiac risk and protecting his heart during noncardiac surgery. |
Nursing
September 2008
Susan Simmons Holcomb |
Acute Abdomen: What a Pain! So many things - some life-threatening - can cause abdominal pain. Here's how to capture the clues quickly and accurately. |
The Motley Fool
November 18, 2010
Brian Orelli |
Genzyme: Slimmed Down, Gussied Up But will anyone buy it? |
The Motley Fool
December 10, 2008
Brian Orelli |
A Painless Advisory Panel Meeting Genzyme might be getting a Christmas present from the Food and Drug Administration. An FDA advisory panel unanimously recommended approval for Genzyme's osteoarthritis pain drug Synvisc-One. |
The Motley Fool
May 5, 2005
Brian Gorman |
Boning Up at Genzyme In its latest acquisition, the biotech claims a line of products from Bone Care. But is the company spreading itself a little too thin? |
The Motley Fool
March 2, 2004
David Nierengarten |
Genzyme's Oncology Acquisitions The biotech gobbles up two smaller firms for their cancer treatment pipelines. |
The Motley Fool
July 12, 2006
Brian Lawler |
Genzyme Continues to Deliver The biopharmaceutical company releases their second quarter earnings announcement. The stock is up sharply today, almost 8%, after Genzyme reported earnings of $0.68 a share. |
The Motley Fool
November 14, 2007
Brian Lawler |
Genzyme Zigs, Shares Zag Genzyme gets downbeat news that will delay the launch of its lead drug, but shares rise. Investors, take note. |
